VCYT vs. SRPT
Compare and contrast key facts about Veracyte, Inc. (VCYT) and Sarepta Therapeutics, Inc. (SRPT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VCYT or SRPT.
Correlation
The correlation between VCYT and SRPT is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VCYT vs. SRPT - Performance Comparison
Key characteristics
VCYT:
1.46
SRPT:
-0.22
VCYT:
2.33
SRPT:
-0.02
VCYT:
1.27
SRPT:
1.00
VCYT:
1.01
SRPT:
-0.26
VCYT:
5.85
SRPT:
-0.57
VCYT:
13.23%
SRPT:
18.84%
VCYT:
53.04%
SRPT:
48.31%
VCYT:
-81.19%
SRPT:
-98.17%
VCYT:
-46.55%
SRPT:
-37.28%
Fundamentals
VCYT:
$3.37B
SRPT:
$11.37B
VCYT:
-$0.13
SRPT:
$1.54
VCYT:
0.00
SRPT:
159.25
VCYT:
$327.13M
SRPT:
$1.24B
VCYT:
$215.32M
SRPT:
$1.05B
VCYT:
$37.55M
SRPT:
$119.07M
Returns By Period
In the year-to-date period, VCYT achieves a 9.85% return, which is significantly higher than SRPT's -7.80% return. Over the past 10 years, VCYT has underperformed SRPT with an annualized return of 17.82%, while SRPT has yielded a comparatively higher 24.78% annualized return.
VCYT
9.85%
2.38%
45.15%
78.57%
10.89%
17.82%
SRPT
-7.80%
-9.94%
-17.81%
-11.06%
-1.10%
24.78%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VCYT vs. SRPT — Risk-Adjusted Performance Rank
VCYT
SRPT
VCYT vs. SRPT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Veracyte, Inc. (VCYT) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VCYT vs. SRPT - Dividend Comparison
Neither VCYT nor SRPT has paid dividends to shareholders.
Drawdowns
VCYT vs. SRPT - Drawdown Comparison
The maximum VCYT drawdown since its inception was -81.19%, smaller than the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for VCYT and SRPT. For additional features, visit the drawdowns tool.
Volatility
VCYT vs. SRPT - Volatility Comparison
Veracyte, Inc. (VCYT) has a higher volatility of 14.24% compared to Sarepta Therapeutics, Inc. (SRPT) at 10.56%. This indicates that VCYT's price experiences larger fluctuations and is considered to be riskier than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VCYT vs. SRPT - Financials Comparison
This section allows you to compare key financial metrics between Veracyte, Inc. and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities